ImmunAdd Inc.
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Other R&D services
We developed a next-generation saponin adjuvant with similar potency to QS-21, but less toxic and suitable for sustainable production. We also developed a small-molecule drug conjugate targeting colorectal cancer.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}